Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Lukas Delasos et al.|Cancer Discovery|2023Cited by 181
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerGiannis Mountzios, Petros Christopoulos, Epaminontas Samantas et al.|ESMO Open|2021Cited by 93
Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsiesPetros Christopoulos, Holger Sültmann|Translational Lung Cancer Research|2021Cited by 21